Unilateral laparoscopic retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular cancer
| Autor: | G. Giusti, Giampaolo Bianchi, C. Tallarigo, Gaetano Mobilio, Paolo Beltrami |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 1998 |
| Předmět: |
Adult
Male medicine.medical_specialty Blood transfusion clinical stage I Urology medicine.medical_treatment Unilateral laparoscopic retroperitoneal lymphadenectomy nonseminomatous testicular cancer Testicular Neoplasms medicine Humans Retroperitoneal Space Laparoscopy Testicular cancer Neoplasm Staging Retrospective Studies Tumor marker medicine.diagnostic_test business.industry Perioperative Middle Aged medicine.disease Surgery Dissection Lymph Node Excision Lymphadenectomy Germinoma medicine.symptom business Orchiectomy Subcutaneous emphysema |
| Popis: | Since June 1993, unilateral laparoscopic retroperitoneal lymph-node dissection (LRPLND) has been performed in six patients with clinical Stage I nonseminomatous germ-cell tumors (NSGCT). All of the patients had undergone prior radical orchiectomy. The testicular cancer was left-sided in three cases and right-sided in three cases. Preoperative staging by means of tumor marker assessment, CT scan of the chest and abdomen, and chest radiography was unremarkable for metastatic disease. All procedures were accomplished without any complications in a mean time of 325 minutes (275-420 minutes). The estimated perioperative and postoperative blood loss was minimal, and none of the patients required blood transfusion. In the case of the first patient, the hospital stay was 18 days because of a widespread subcutaneous emphysema. In the remaining five cases, the average hospitalization was 4.8 days (range 4-6 days). The patients resumed normal activities within 12 to 27 days (mean 16.16 days) postoperatively. The mean number of lymph nodes removed was 6.8 (range 5-9). Histologic examination of these nodes revealed microscopic metastases from embryonal carcinoma in two patients, both of whom were subjected to adjuvant chemotherapy. The mean follow-up period is 27.1 months (range 12-42 months). To date, no relapses have been observed. In accordance with other reports, we believe that LRPLND is both feasible and effective. However, larger and more comprehensive studies with long-term follow-up are required to determine whether this approach is reliable and definitely superior to standard open surgery in the management of clinical Stage I NSGCT. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|